ACS Applied Materials & Interfaces · 2020 · 54 citations · 24 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryMolecular PharmacologyNanoparticle Drug DeliveryCell-nanoparticle InteractionsNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignNanoparticle FormulationsAntimalarial AgentsAntimalarial ChemotherapyAntimalarial Drug DevelopmentGold Nanoparticle Drug DeliveryMolecular Drug ResistanceParasite Drug ResistancePlasmodium FalciparumTreatment Of Malaria
Malaria, a mosquito-borne disease caused by Plasmodium species, claims more than 400,000 lives globally each year. The increasing drug resistance of the parasite renders the development of new anti-malaria drugs necessary. Alternatively, better delivery systems for already marketed drugs could help to solve the resistance problem. Herein, we report glucose-based ultra-small gold nanoparticles (Glc-NCs) that bind to cysteine-rich domains of Plasmodium falciparum surface proteins. Microscopy shows that Glc-NCs bind specifically to extracellular and all intra-erythrocytic stages of P. falciparum. Glc-NCs may be used as drug delivery agents as illustrated for ciprofloxacin, a poorly soluble antibiotic with low antimalarial activity. Ciprofloxacin conjugated to Glc-NCs is more water-soluble than the free drug and is more potent. Glyco-gold nanoparticles that target cysteine-rich domains on parasites may be helpful for the prevention and treatment of malaria.
24
A Central Role for P48/45 in Malaria Parasite Male Gamete Fertility
Melissa R. van Dijk, Chris J. Janse, Joanne Thompson et al. · Cell · 2001 · 439 citations · Full text